14.09
price down icon1.47%   -0.21
after-market アフターアワーズ: 14.05 -0.04 -0.28%
loading

Regenxbio Inc (RGNX) 最新ニュース

pulisher
12:38 PM

REGENXBIO (NASDAQ:RGNX) Trading Down 3.8%Here's Why - MarketBeat

12:38 PM
pulisher
Dec 23, 2025

REGENXBIO Inc. (NASDAQ:RGNX) Surges 27% Yet Its Low P/S Is No Reason For Excitement - simplywall.st

Dec 23, 2025
pulisher
Dec 22, 2025

Behavioral Patterns of RGNX and Institutional Flows - Stock Traders Daily

Dec 22, 2025
pulisher
Dec 22, 2025

REGENXBIO (NASDAQ:RGNX) Hits New 1-Year HighWhat's Next? - MarketBeat

Dec 22, 2025
pulisher
Dec 22, 2025

Assenagon Asset Management S.A. Purchases 132,942 Shares of REGENXBIO Inc. $RGNX - MarketBeat

Dec 22, 2025
pulisher
Dec 22, 2025

REGENXBIO Inc. (NASDAQ:RGNX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat

Dec 22, 2025
pulisher
Dec 20, 2025

Stifel raises Regenxbio stock price target to $45 on upcoming catalysts By Investing.com - Investing.com Australia

Dec 20, 2025
pulisher
Dec 19, 2025

Stifel Maintains REGENXBIO (RGNX) Buy Recommendation - Nasdaq

Dec 19, 2025
pulisher
Dec 19, 2025

REGENXBIO (NASDAQ:RGNX) Shares Up 9.2%What's Next? - MarketBeat

Dec 19, 2025
pulisher
Dec 19, 2025

What hedge fund activity signals for REGENXBIO Inc. stockCPI Data & Breakout Confirmation Trade Signals - DonanımHaber

Dec 19, 2025
pulisher
Dec 19, 2025

Stifel Raises Price Target for Regenxbio (RGNX) to $45 | RGNX St - GuruFocus

Dec 19, 2025
pulisher
Dec 19, 2025

Stifel raises Regenxbio stock price target to $45 on upcoming catalysts - Investing.com Nigeria

Dec 19, 2025
pulisher
Dec 19, 2025

Decliners Report: How interest rate cuts could boost REGENXBIO Inc. stockQuarterly Profit Review & Risk Adjusted Buy/Sell Alerts - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

Why REGENXBIO Inc. stock is recommended by analystsTreasury Yields & Detailed Earnings Play Alerts - DonanımHaber

Dec 19, 2025
pulisher
Dec 19, 2025

Squarepoint Ops LLC Boosts Holdings in REGENXBIO Inc. $RGNX - MarketBeat

Dec 19, 2025
pulisher
Dec 19, 2025

Will REGENXBIO Inc. stock reach Wall Street targetsForecast Cut & Daily Profit Focused Stock Screening - DonanımHaber

Dec 19, 2025
pulisher
Dec 18, 2025

Is REGENXBIO Inc. stock a smart buy before Fed meetingJuly 2025 Trends & Scalable Portfolio Growth Ideas - ulpravda.ru

Dec 18, 2025
pulisher
Dec 18, 2025

How interest rate cuts could boost REGENXBIO Inc. stockPortfolio Gains Report & Consistent Return Investment Signals - Улправда

Dec 18, 2025
pulisher
Dec 18, 2025

Is REGENXBIO Inc. stock a contrarian buy2025 Risk Factors & Fast Entry Momentum Trade Alerts - Улправда

Dec 18, 2025
pulisher
Dec 18, 2025

REGENXBIO to Present at the 44th Annual J.P. Morgan Healthcare Conference - The AI Journal

Dec 18, 2025
pulisher
Dec 16, 2025

Leerink Partners Maintains REGENXBIO (RGNX) Outperform Recommendation - Nasdaq

Dec 16, 2025
pulisher
Dec 15, 2025

Leerink Partners raises Regenxbio stock price target to $20 on DMD opportunity By Investing.com - Investing.com South Africa

Dec 15, 2025
pulisher
Dec 15, 2025

Regenxbio (RGNX): Leerink Partners Raises Price Target to USD 20 - GuruFocus

Dec 15, 2025
pulisher
Dec 15, 2025

Leerink Partners raises Regenxbio stock price target to $20 on DMD opportunity - Investing.com Nigeria

Dec 15, 2025
pulisher
Dec 15, 2025

REGENXBIO (NASDAQ:RGNX) Reaches New 1-Year HighWhat's Next? - MarketBeat

Dec 15, 2025
pulisher
Dec 15, 2025

RegenXBio’s gene therapy study for Hunter syndrome: A potential game-changer - MSN

Dec 15, 2025
pulisher
Dec 14, 2025

RegenXBio’s Gene Therapy Study for Hunter Syndrome: A Potential Game-Changer - TipRanks

Dec 14, 2025
pulisher
Dec 13, 2025

REGENXBIO (NASDAQ:RGNX) Stock Price Up 5.2%Time to Buy? - MarketBeat

Dec 13, 2025
pulisher
Dec 11, 2025

(RGNX) Movement Within Algorithmic Entry Frameworks - news.stocktradersdaily.com

Dec 11, 2025
pulisher
Dec 08, 2025

REGENXBIO (NASDAQ:RGNX) Reaches New 52-Week HighShould You Buy? - MarketBeat

Dec 08, 2025
pulisher
Dec 08, 2025

Wet Age-Related Macular Degeneration Market Growth - openPR.com

Dec 08, 2025
pulisher
Dec 08, 2025

Voss Capital LP Boosts Stock Holdings in REGENXBIO Inc. $RGNX - MarketBeat

Dec 08, 2025
pulisher
Dec 08, 2025

REGENXBIO Inc. $RGNX is 22NW LP's 5th Largest Position - MarketBeat

Dec 08, 2025
pulisher
Dec 06, 2025

Regenxbio Stock Jump Looks Great, But How Secure Is That Gain? - Trefis

Dec 06, 2025
pulisher
Dec 05, 2025

Will REGENXBIO Inc. (RB0) stock announce special dividend2025 Major Catalysts & Real-Time Volume Spike Alerts - Newser

Dec 05, 2025
pulisher
Dec 05, 2025

What insider trading reveals about REGENXBIO Inc. stockJuly 2025 Snapshot & Smart Allocation Stock Tips - Newser

Dec 05, 2025
pulisher
Dec 05, 2025

Why global investors buy REGENXBIO Inc. (RB0) stock2025 Market WrapUp & Safe Capital Allocation Plans - Newser

Dec 05, 2025
pulisher
Dec 04, 2025

Will REGENXBIO Inc. (RB0) stock profit from fiscal stimulus2025 Big Picture & Safe Entry Zone Identification - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Can REGENXBIO Inc. stock resist market sell offsQuarterly Profit Review & Technical Pattern Based Signals - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Is REGENXBIO Inc. stock resilient to inflationGold Moves & Fast Exit Strategy with Risk Control - Newser

Dec 04, 2025
pulisher
Dec 03, 2025

JPMorgan Chase & Co. Sells 512,318 Shares of REGENXBIO Inc. $RGNX - MarketBeat

Dec 03, 2025
pulisher
Dec 02, 2025

Will REGENXBIO Inc. (RB0) stock see valuation expansionWeekly Trade Analysis & Reliable Trade Execution Plans - Newser

Dec 02, 2025
pulisher
Dec 01, 2025

REGENXBIO announces royalty monetization agreement for up to $250M - MSN

Dec 01, 2025
pulisher
Dec 01, 2025

Commercial Lessons From The Cell And Gene Therapy Frontlines - Citeline News & Insights

Dec 01, 2025
pulisher
Nov 30, 2025

How (RGNX) Movements Inform Risk Allocation Models - news.stocktradersdaily.com

Nov 30, 2025
pulisher
Nov 30, 2025

26,773 Shares in REGENXBIO Inc. $RGNX Bought by Rockefeller Capital Management L.P. - MarketBeat

Nov 30, 2025
pulisher
Nov 28, 2025

REGENXBIO Inc. (NASDAQ:RGNX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat

Nov 28, 2025
$38.99
price down icon 0.23%
$31.49
price down icon 3.17%
$98.91
price down icon 0.38%
$95.28
price up icon 0.08%
biotechnology ONC
$304.72
price down icon 1.80%
$174.09
price down icon 1.28%
大文字化:     |  ボリューム (24 時間):